The global Lorlatinib market size was valued at US$ 567 million in 2024 and is projected to reach US$ 978 million by 2030, at a CAGR of 9.5% during the forecast period 2024-2030.
United States Lorlatinib market size was valued at US$ 185 million in 2024 and is projected to reach US$ 307 million by 2030, at a CAGR of 8.8% during the forecast period 2024-2030.
A third-generation ALK inhibitor used in the treatment of ALK-positive metastatic NSCLC.
Strong growth supported by efficacy in patients with brain metastases and those resistant to first-generation ALK inhibitors. Expanding indications as first-line therapy. Ongoing clinical trials for combination therapies.
Report Overview
This report provides a deep insight into the global Lorlatinib market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Lorlatinib Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Lorlatinib market in any manner.
Global Lorlatinib Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Market Segmentation (by Type)
Market Segmentation (by Application)
- Squamous Cell Carcinoma of NSCLC
- Adenocarcinoma of NSCLC
- Large Cell Carcinoma of NSCLC
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Lorlatinib Market
- Overview of the regional outlook of the Lorlatinib Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the
major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Lorlatinib
1.2 Key Market Segments
1.2.1 Lorlatinib Segment by Type
1.2.2 Lorlatinib Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Lorlatinib Market Overview
2.1 Global Market Overview
2.1.1 Global Lorlatinib Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Lorlatinib Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Lorlatinib Market Competitive Landscape
3.1 Global Lorlatinib Sales by Manufacturers (2019-2024)
3.2 Global Lorlatinib Revenue Market Share by Manufacturers (2019-2024)
3.3 Lorlatinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Lorlatinib Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Lorlatinib Sales Sites, Area Served, Product Type
3.6 Lorlatinib Market Competitive Situation and Trends
3.6.1 Lorlatinib Market Concentration Rate
3.6.2 Global 5 and 10 Largest Lorlatinib Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Lorlatinib Industry Chain Analysis
4.1 Lorlatinib Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Lorlatinib Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Lorlatinib Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lorlatinib Sales Market Share by Type (2019-2024)
6.3 Global Lorlatinib Market Size Market Share by Type (2019-2024)
6.4 Global Lorlatinib Price by Type (2019-2024)
7 Lorlatinib Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lorlatinib Market Sales by Application (2019-2024)
7.3 Global Lorlatinib Market Size (M USD) by Application (2019-2024)
7.4 Global Lorlatinib Sales Growth Rate by Application (2019-2024)
8 Lorlatinib Market Segmentation by Region
8.1 Global Lorlatinib Sales by Region
8.1.1 Global Lorlatinib Sales by Region
8.1.2 Global Lorlatinib Sales Market Share by Region
8.2 North America
8.2.1 North America Lorlatinib Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Lorlatinib Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Lorlatinib Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Lorlatinib Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Lorlatinib Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Pfizer
9.1.1 Pfizer Lorlatinib Basic Information
9.1.2 Pfizer Lorlatinib Product Overview
9.1.3 Pfizer Lorlatinib Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Lorlatinib SWOT Analysis
9.1.6 Pfizer Recent Developments
10 Lorlatinib Market Forecast by Region
10.1 Global Lorlatinib Market Size Forecast
10.2 Global Lorlatinib Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Lorlatinib Market Size Forecast by Country
10.2.3 Asia Pacific Lorlatinib Market Size Forecast by Region
10.2.4 South America Lorlatinib Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Lorlatinib by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Lorlatinib Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Lorlatinib by Type (2025-2030)
11.1.2 Global Lorlatinib Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Lorlatinib by Type (2025-2030)
11.2 Global Lorlatinib Market Forecast by Application (2025-2030)
11.2.1 Global Lorlatinib Sales (Kilotons) Forecast by Application
11.2.2 Global Lorlatinib Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Lorlatinib Market Size Comparison by Region (M USD)
Table 5. Global Lorlatinib Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Lorlatinib Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Lorlatinib Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Lorlatinib Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lorlatinib as of 2022)
Table 10. Global Market Lorlatinib Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Lorlatinib Sales Sites and Area Served
Table 12. Manufacturers Lorlatinib Product Type
Table 13. Global Lorlatinib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Lorlatinib
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Lorlatinib Market Challenges
Table 22. Global Lorlatinib Sales by Type (Kilotons)
Table 23. Global Lorlatinib Market Size by Type (M USD)
Table 24. Global Lorlatinib Sales (Kilotons) by Type (2019-2024)
Table 25. Global Lorlatinib Sales Market Share by Type (2019-2024)
Table 26. Global Lorlatinib Market Size (M USD) by Type (2019-2024)
Table 27. Global Lorlatinib Market Size Share by Type (2019-2024)
Table 28. Global Lorlatinib Price (USD/Ton) by Type (2019-2024)
Table 29. Global Lorlatinib Sales (Kilotons) by Application
Table 30. Global Lorlatinib Market Size by Application
Table 31. Global Lorlatinib Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Lorlatinib Sales Market Share by Application (2019-2024)
Table 33. Global Lorlatinib Sales by Application (2019-2024) & (M USD)
Table 34. Global Lorlatinib Market Share by Application (2019-2024)
Table 35. Global Lorlatinib Sales Growth Rate by Application (2019-2024)
Table 36. Global Lorlatinib Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Lorlatinib Sales Market Share by Region (2019-2024)
Table 38. North America Lorlatinib Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Lorlatinib Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Lorlatinib Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Lorlatinib Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Lorlatinib Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Lorlatinib Basic Information
Table 44. Pfizer Lorlatinib Product Overview
Table 45. Pfizer Lorlatinib Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer Lorlatinib SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. Global Lorlatinib Sales Forecast by Region (2025-2030) & (Kilotons)
Table 50. Global Lorlatinib Market Size Forecast by Region (2025-2030) & (M USD)
Table 51. North America Lorlatinib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 52. North America Lorlatinib Market Size Forecast by Country (2025-2030) & (M USD)
Table 53. Europe Lorlatinib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 54. Europe Lorlatinib Market Size Forecast by Country (2025-2030) & (M USD)
Table 55. Asia Pacific Lorlatinib Sales Forecast by Region (2025-2030) & (Kilotons)
Table 56. Asia Pacific Lorlatinib Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. South America Lorlatinib Sales Forecast by Country (2025-2030) & (Kilotons)
Table 58. South America Lorlatinib Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Middle East and Africa Lorlatinib Consumption Forecast by Country (2025-2030) & (Units)
Table 60. Middle East and Africa Lorlatinib Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Global Lorlatinib Sales Forecast by Type (2025-2030) & (Kilotons)
Table 62. Global Lorlatinib Market Size Forecast by Type (2025-2030) & (M USD)
Table 63. Global Lorlatinib Price Forecast by Type (2025-2030) & (USD/Ton)
Table 64. Global Lorlatinib Sales (Kilotons) Forecast by Application (2025-2030)
Table 65. Global Lorlatinib Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Lorlatinib
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lorlatinib Market Size (M USD), 2019-2030
Figure 5. Global Lorlatinib Market Size (M USD) (2019-2030)
Figure 6. Global Lorlatinib Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Lorlatinib Market Size by Country (M USD)
Figure 11. Lorlatinib Sales Share by Manufacturers in 2023
Figure 12. Global Lorlatinib Revenue Share by Manufacturers in 2023
Figure 13. Lorlatinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Lorlatinib Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Lorlatinib Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Lorlatinib Market Share by Type
Figure 18. Sales Market Share of Lorlatinib by Type (2019-2024)
Figure 19. Sales Market Share of Lorlatinib by Type in 2023
Figure 20. Market Size Share of Lorlatinib by Type (2019-2024)
Figure 21. Market Size Market Share of Lorlatinib by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Lorlatinib Market Share by Application
Figure 24. Global Lorlatinib Sales Market Share by Application (2019-2024)
Figure 25. Global Lorlatinib Sales Market Share by Application in 2023
Figure 26. Global Lorlatinib Market Share by Application (2019-2024)
Figure 27. Global Lorlatinib Market Share by Application in 2023
Figure 28. Global Lorlatinib Sales Growth Rate by Application (2019-2024)
Figure 29. Global Lorlatinib Sales Market Share by Region (2019-2024)
Figure 30. North America Lorlatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Lorlatinib Sales Market Share by Country in 2023
Figure 32. U.S. Lorlatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Lorlatinib Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Lorlatinib Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Lorlatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Lorlatinib Sales Market Share by Country in 2023
Figure 37. Germany Lorlatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Lorlatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Lorlatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Lorlatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Lorlatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Lorlatinib Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Lorlatinib Sales Market Share by Region in 2023
Figure 44. China Lorlatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Lorlatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Lorlatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Lorlatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Lorlatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Lorlatinib Sales and Growth Rate (Kilotons)
Figure 50. South America Lorlatinib Sales Market Share by Country in 2023
Figure 51. Brazil Lorlatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Lorlatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Lorlatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Lorlatinib Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Lorlatinib Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Lorlatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Lorlatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Lorlatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Lorlatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Lorlatinib Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Lorlatinib Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Lorlatinib Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Lorlatinib Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Lorlatinib Market Share Forecast by Type (2025-2030)
Figure 65. Global Lorlatinib Sales Forecast by Application (2025-2030)
Figure 66. Global Lorlatinib Market Share Forecast by Application (2025-2030)
